The abstract is read at the publisher; the summary is JClub's.
Platelet-activating factor receptor upregulation in mouse renal tubular epithelial cells is linked to G2/M arrest in AKI-to-CKD transition via reduced mouse double minute 2–mediated p53 ubiquitin degradation.
- Why it matters: Effective therapies are limited for AKI patients who progress to CKD, and the receptor-driven mechanisms in tubular cells remain unclear.
- What they did: Using bilateral renal artery clamping to model ischemia-reperfusion injury, the study used tubule-specific PTAFR deficiency plus transcriptomics, flow cytometry, coimmunoprecipitation, Western blotting, and lipidomics; it also tested the PTAFR antagonist WAY-639497 identified by virtual screening.
- The result: Phosphatidylethanolamine (18:0/18:1) was identified as a PTAFR endogenous ligand that induces G2/M arrest, urinary (18:0/18:1) distinguished AKI from healthy controls, and WAY-639497 mitigated tubular injury and kidney fibrosis after AKI.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.